Biotechnology in Europe
- Pages: 44
- Published: December 2019
- Report Code: OHMF9200
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
– The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
– The European biotechnology industry had total revenues of $75.0bn in 2018, representing a compound annual growth rate (CAGR) of 6.3% between 2014 and 2018.
– The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of $47.4bn, equivalent to 63.2% of the industry's overall value.
– The medical/healthcare segment makes up the majority of the European industry. This is because in developed nations in Europe, an aging population has driven demand in the medical/healthcare segment, as an increasing number of people are suffering from long-term chronic diseases and healthcare costs have increased.
Scope
– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
– Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts
Reasons to buy
- What was the size of the Europe biotechnology market by value in 2018?
- What will be the size of the Europe biotechnology market in 2023?
- What factors are affecting the strength of competition in the Europe biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Europe's biotechnology market?
Companies mentioned
Merck & Co., Inc.
Boehringer Ingelheim GmbH
AstraZeneca PLC
F. Hoffmann-La Roche Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.